The Association of Southeast Asian Nations (ASEAN) is a key regional cooperation organization in Southeast Asia, encompassing 11 countries in the region. With a population exceeding 680 million and a combined economic output of over US$ 3 trillion, it has become a vital region for the shifting of global supply chains, manufacturing investment, and consumption growth.

In vitro diagnostics (IDV) refers to products and services that obtain clinical diagnostic information by testing human samples (blood, body fluids, tissues, etc.) outside the human body, thereby determining diseases or bodily functions. IVD products include diagnostic equipment and diagnostic reagents.

The ASEAN in vitro diagnostics market is demonstrating strong growth momentum, driven primarily by factors such as the high prevalence of infectious diseases, the rising burden of chronic diseases, the expansion of healthcare infrastructure, and the growth of medical tourism and private healthcare.

ASEAN countries have weak domestic IVD manufacturing capabilities. Apart from a small amount of research and production in Singapore, most countries rely on imports, with an import dependency rate of over 60%.

Singapore is the only IVD manufacturing hub in the region, hosting the regional headquarters and R&D centers of numerous multinational corporations.

In recent years, the in vitro diagnostics (IVD) market in ASEAN has expanded continuously and rapidly.

According to CRI estimates, the market size for IVD in ASEAN is approximately US$ 4.7 billion in 2026. It is projected to reach approximately US$ 7.0 billion by 2030, with a compound annual growth rate of about 9.0%.

CRI recommends that global manufacturers of in vitro diagnostic equipment and reagents, medical device manufacturers, medical device distributors, private equity (PE) funds and venture capital (VC) firms conduct timely market research on the ASEAN region to prepare for their strategic entry into the ASEAN in vitro diagnostics (IVD) market.

Key Contents

• Overview of the In Vitro Diagnostics (IVD) Industry in ASEAN
• Economic and Policy Environment of In Vitro Diagnostics (IVD) Industry in ASEAN
• Analysis of the In Vitro Diagnostics (IVD) Industry in Major ASEAN Countries
• Market Size of In Vitro Diagnostics (IVD) in ASEAN (2021–2025)
• Analysis of Major Manufacturers of In Vitro Diagnostic Products in ASEAN
• Key Drivers and Market Opportunities of In Vitro Diagnostics (IVD) Industry in ASEAN
• What are the key drivers, challenges and opportunities for the ASEAN in vitro diagnostics (IVD) industry during the forecast period of 2026–2030?
• Which companies are the major market players in the ASEAN in vitro diagnostics (IVD) industry and what are their competitive advantages?
• What is the projected revenue for in vitro diagnostics (IVD) market in ASEAN during the forecast period of 2026–2030?
• What strategies have major market players adopted to increase their market share within this industry?
• Which segment of the ASEAN in vitro diagnostics (IVD) market is expected to dominate the market by 2030?
• What are the major headwinds facing the ASEAN in vitro diagnostics (IVD) industry?
• How can foreign capital enter the in vitro diagnostics (IVD) industry in ASEAN?

Table of Contents

1 Overview of ASEAN

1.1 Geography

1.2 Demographic Structure

1.3 Economic Situation

1.4 Minimum Wage Standards

2 Overview of the In Vitro Diagnostics (IVD) Industry

2.1 Definition and Classification of the In Vitro Diagnostics (IVD) Industry

2.1.1 Industry Definition

2.1.2 Classification

2.2 Analysis of In Vitro Diagnostics (IVD) Industry Chain

2.3 Policy Environment of In Vitro Diagnostics (IVD) Industry in ASEAN

2.4 CRI’s Suggestions for Foreign-Invested Enterprises Investing in the ASEAN In Vitro Diagnostics (IVD) Industry

3 Analysis of Supply and Demand in the ASEAN In Vitro Diagnostics (IVD) Industry

3.1 Supply Analysis of the In Vitro Diagnostics (IVD) Industry in ASEAN

3.1.1 Analysis of Manufacturing Capabilities for In Vitro Diagnostic Equipment and Reagents in ASEAN

3.1.2 Supply Structure of In Vitro Diagnostics (IVD) and Reagents in ASEAN

3.1.3 Factors Affecting the Manufacturing of In Vitro Diagnostic Equipment and Reagents in ASEAN

3.2 Demand Analysis of In Vitro Diagnostics (IVD) Industry in ASEAN

3.2.1 Market Size of In Vitro Diagnostic Equipment and Reagents

3.2.2 Analysis of the Demand Structure for In Vitro Diagnostic Equipment and Reagents

3.2.3 Analysis of Market Demand Across Different Countries and Regions

3.2.4 Analysis of Drivers of Demand for In Vitro Diagnostics

4 Import and Export of In Vitro Diagnostic Equipment and Reagents in ASEAN

4.1 Import Overview of In Vitro Diagnostic Equipment and Reagents in ASEAN

4.1.1 Import Value of In Vitro Diagnostic Equipment and Reagents in ASEAN

4.1.2 Major Sources of In Vitro Diagnostic Equipment and Reagents Imports in ASEAN

4.2 Export Overview of In Vitro Diagnostic Equipment and Reagents in ASEAN

4.2.1 Export Value of In Vitro Diagnostic Equipment and Reagents in ASEAN

4.2.2 Major Destinations for In Vitro Diagnostic Equipment and Reagents in ASEAN

5 Analysis of the In Vitro Diagnostics (IVD) Industry in Major ASEAN Countries

5.1 Singapore

5.1.1 Overview of the In Vitro Diagnostics (IVD) Industry

5.1.2 Analysis of In Vitro Diagnostics (IVD) Market Supply and Demand

5.2 Malaysia

5.2.1 Overview of the In Vitro Diagnostics (IVD) Industry

5.2.2 Analysis of In Vitro Diagnostics (IVD) Market Supply and Demand

5.3 Thailand

5.3.1 Overview of the In Vitro Diagnostics (IVD) Industry

5.3.2 Analysis of In Vitro Diagnostics (IVD) Market Supply and Demand

5.4 Indonesia

5.4.1 Overview of the In Vitro Diagnostics (IVD) Industry

5.4.2 Analysis of In Vitro Diagnostics (IVD) Market Supply and Demand

5.5 Vietnam

5.5.1 Overview of the In Vitro Diagnostics (IVD) Industry

5.5.2 Analysis of In Vitro Diagnostics (IVD) Market Supply and Demand

6 Analysis of the Top 5 In Vitro Diagnostics (IVD) Providers in ASEAN

6.1 Roche Diagnostics

6.1.1 Company Overview

6.1.2 Operations Status

6.2 Abbott

6.2.1 Company Overview

6.2.2 Operations Status

6.3 Vero Test

6.3.1 Company Overview

6.3.2 Operations Status

6.4 MiRXES

6.4.1 Company Overview

6.4.2 Operations Status

6.5 Reszon Diagnostics International

6.5.1 Company Overview

6.5.2 Operations Status

7 Outlook of In Vitro Diagnostics (IVD) Industry in ASEAN 2026-2030

7.1 Analysis of Development Factors of In Vitro Diagnostics (IVD) Industry in ASEAN

7.1.1 Drivers and Growth Opportunities of In Vitro Diagnostics (IVD) Industry in ASEAN

7.1.2 Threats and Challenges Facing of In Vitro Diagnostics (IVD) Industry in ASEAN

7.2 Forecast of Supply for In Vitro Diagnostics (IVD) Industry in ASEAN

7.3 Forecast of Demand for In Vitro Diagnostics (IVD) in ASEAN

7.4 Forecast of Imports and Exports for In Vitro Diagnostics (IVD) Industry in ASEAN

List of Some Charts

Chart Total Population in ASEAN, 2021–2025

Chart Per Capita GDP in ASEAN, 2021–2025

Chart Policies Related to the Healthcare Security and Investment Issued in ASEAN, 2021–2025

Chart Per Capita Healthcare Expenditure in ASEAN, 2021-2025

Chart Number of Private Hospitals in ASEAN, 2021-2025

Chart Number of Public Hospitals in ASEAN, 2021-2025

Chart Number of Medical Chain Institutions in ASEAN, 2021-2025

Chart Market Size of In Vitro Diagnostics (IVD) in ASEAN, 2021–2025

Chart Market Size of In Vitro Diagnostics (IVD) in Singapore, 2021–2025

Chart Market Size of In Vitro Diagnostics (IVD) in Malaysia, 2021–2025

Chart Market Size of In Vitro Diagnostics (IVD) in Thailand, 2021–2025

Chart Market Size of In Vitro Diagnostics (IVD) in Indonesia, 2021-2025

Chart Market Size of In Vitro Diagnostics (IVD) in Vietnam, 2021-2025

Chart Imports of In Vitro Diagnostic Equipment and Reagents in ASEAN, 2021–2025

Chart Exports of In Vitro Diagnostic Equipment and Reagents in ASEAN, 2021–2025

Chart Market Size Forecast of In Vitro Diagnostics (IVD) in ASEAN, 2026–2030

Chart Import and Export Forecast of In Vitro Diagnostic Equipment and Reagents in ASEAN, 2026-2030

The post ASEAN In Vitro Diagnostics (IVD) Industry Research Report 2026-2030 first appeared on CRI Report.